Weight Loss Drugs & Medicare

Created by Melinda Caughill, Modified on Wed, 22 Oct at 9:37 AM by Melinda Caughill

It can be very frustrating when medications you take are not covered by Medicare Part D plans. One of the hardest categories to deal with on Medicare lately is weight loss drugs.


The Social Security Act spells out the rules for coverage of medications and excludes certain categories from coverage under Medicare, including “weight loss (even if used for a non-cosmetic purpose (i.e., morbid obesity).”


Medications that can be covered under Medicare Part D drug plans are approved by the FDA for medical reasons other than weight loss, such as diabetes or cardiovascular risk, which include Wegovy, Ozempic and Mounjarno. 


Medications approved by the FDA for purposes other than weight loss can be covered by Part D drug plans but that does not guarantee that these medications will be included in a drug plan’s formulary. (A formulary is a list of medication covered by a specific Part D plan.)

  • According to Medicare rules, Medicare Part D plans must include "substantially all" drugs in six protected categories and classes. (No clear definition of what "substantially all" actually means.)
    • Anticonvulsants: Drugs to treat seizures and other seizure disorders. 
    • Antidepressants: Medications for depression and other mental health conditions. 
    • Antineoplastics: Cancer medications. 
    • Antipsychotics: Drugs for mental illnesses such as schizophrenia. 
    • Antiretrovirals: Medications used to treat HIV/AIDS. 
    • Immunosuppressants: Drugs to prevent organ transplant rejection.

  • Outside of those six protected categories and classes, the rule is that Medicare Part D plans must cover at least two drugs in the most commonly prescribed categories and classes.
    • At least two drugs can mean just two drugs
    • The most commonly prescribed categories and classes does NOT mean all categories and classes.


Medicare Part D plans may not cover any medications in the categories and classes not considered to be the most commonly prescribed.


GLP-1 generics, Zepbound, Saxenda and other medications simply for weight loss are not covered by Medicare and any Part D drug plan.


Check these links for additional information. 


Alternative Methods for Obtaining Weight Loss Drugs



Allowed When Enrolled in Medicare

Best For

Potential Savings

Pharmacy Discount Programs (GoodRx, SingleCare, etc.)

Yes

Paying Cash

Moderate

Manufacturer Savings Programs 

No

Insured by Employer/Marketplace Plans

$150/month

Manufacturer Patient Assistance Programs

Yes

Income below 500% federal poverty level

Free

International Mail Order Pharmacies

Gray Area

People who are OK that importing prescriptions is technically not FDA-approved

Moderate

Local compounding pharmacies

Yes

People who want locally sourced meds; Feel comfortable with these meds not being FDA-approved

Generic  versus brand savings

Switching to a drug covered by Part D plans

Yes

People with diabetes or other specific medical conditions

Full insurance coverage

Using HSA/FSA funds

Yes

People with HSA/FSA funds

Tax savings only

National telehealth providers (Ro.co, Hims/hers, Noom, etc.)

Yes

Paying cash, Getting telehealth support

Moderate

Retailers like CVS, Costco, Walmart that are now offering discounts

Yes

Paying cash, Maximizing savings for uncovered medications

Moderate
Learn more

Apply for a formulary exception*

Yes

When your doctor believes the medication is critical to a stabilizing a chronic health condition

Full insurance coverage


*Formulary Exceptions For Drugs Not Covered by Part D Plans

In the middle of a plan year, if you need a medication that your drug plan does not cover, your physician can request a Formulary Exception.


This would allow you to:

  • Obtain a Part D drug that is not included on a plan sponsor’s formulary, *OR*
  • Obtain a formulary drug that is subject to a utilization management restriction (e.g., step therapy, prior authorization, quantity limit).

The physician’s supporting statement must indicate that the non-formulary drug is necessary for treating a condition because all covered Part D drugs would not be as effective or would have adverse effects.


If the plan sponsor denies the request, there is an appeal process. 


Check these links for more information:


Was this article helpful?

That’s Great!

Thank you for your feedback

Sorry! We couldn't be helpful

Thank you for your feedback

Let us know how can we improve this article!

Select at least one of the reasons
CAPTCHA verification is required.

Feedback sent

We appreciate your effort and will try to fix the article